Skip over left navigation and go straight to content

New Frontiers in Personalized Medicine: Cardiovascular Research & Clinical Care

Event Speaker(s)



Michael Bristow, M.D., Ph.D., CEO, Chief Science and Medical Officer, ARCA Biopharma

Michael Caldwell, M.D., Ph.D., FACS, Director, Wound Healing Program, Marshfield Clinic Topic: Pharmacogenetic Approaches to Warfarin Dosing

Pierre Cassigneul, President and CEO, XDx

Victor Dzau, M.D., President and CEO, Duke University Health System and Chancellor for Health Affairs, Duke University

Jennifer Van Eyk, Ph.D., Director, The Johns Hopkins NHLBI Proteomics Center

Geoffrey Ginsburg, M.D., Ph.D., Director, Center for Genomic Medicine, Institute for Genome Sciences and Policy, Duke University

Richard Katz, M.D., Bloedorn Professor of Medicine and Division Director, the George Washington University Richard B. and Lynne V. Cheney Cardiovascular Institute

Bruce Korf, M.D., Ph.D., Chair of the UAB Department of Genetics, University of Alabama at Birmingham

Jack Lewin, M.D., CEO, American College of Cardiology

Timothy McCaffrey, Ph.D., Professor of Medicine and Director, Division of Genomic On Medicine, the George Washington University

Christopher Newton-Cheh, M.D., MPH, Cardiologist, Massachusetts General Hospital

Andrew Plump, M.D., Ph.D., Vice President and Cardiovascular Disease Franchise Worldwide Basic Research Head, Merck

Ben Salisbury, Ph.D., Vice President, Clinical Genetics, PGxHealth

Steve Rosenberg, Ph.D., Chief Science Officer, CardioDx

Vicki Seyfert-Margolis, Ph.D., Senior Advisor, Science Innovation and Policy, Office of the Chief Scientist, Office of the Commissioner, Food and Drug Administration

Susan Shurin, M.D., Acting Director, National Heart, Lung, and Blood Institute, National Institutes of Health

John Spertus, M.D., MPH, Lauer/Missouri Endowed Chair and Professor, University of Missouri – Kansas City and Clinical Director of Outcomes Research, St. Luke’s Mid America Heart Institute

Jean-Claude Tardif, M.D., Professor of Medicine, Director of the Research Centre, Montreal Heart Institute

Russell Teagarden, Ph.D., Vice President, Clinical Practices and Therapeutics, Medco Health Solutions, Inc.

Jay Wohlgemuth, M.D., Vice President, Science and Innovation, Quest Diagnostics Nichols Institute






Last Updated January 2012

Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon